LEUKEMIA, MYELOID, ACUTE
Clinical trials for LEUKEMIA, MYELOID, ACUTE explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, MYELOID, ACUTE trials appear
Sign up with your email to follow new studies for LEUKEMIA, MYELOID, ACUTE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to delay progression in blood cancers
Disease control CompletedThis study tested whether adding pevonedistat to the standard drug azacitidine helps people with certain blood cancers live longer without their disease getting worse. It included 454 adults with higher-risk myelodysplastic syndromes, chronic myelomonocytic leukemia, or low-blast…
Matched conditions: LEUKEMIA, MYELOID, ACUTE
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated May 17, 2026 02:07 UTC
-
Dietary change may cut c. diff recurrence in cancer patients
Disease control CompletedThis study looked at whether eating less fat and more fiber can lower the chance of a repeat Clostridioides difficile infection in people being treated for cancer. Eight patients with leukemia, lymphoma, or other cancers who had a recent C. diff infection took part. Researchers t…
Matched conditions: LEUKEMIA, MYELOID, ACUTE
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated May 17, 2026 02:01 UTC
-
New drug combo shows promise for AML patients
Disease control CompletedThis study tested a combination of two drugs, azacitidine and venetoclax, in 40 adults aged 45 to 65 with newly diagnosed acute myeloid leukemia (AML). The goal was to see how well the treatment worked and how safe it was. Participants received the drugs and were monitored for re…
Matched conditions: LEUKEMIA, MYELOID, ACUTE
Phase: NA • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Experimental drug shows promise for tough-to-treat leukemia after transplant
Disease control CompletedThis early-stage study tested a drug called flotetuzumab in 3 adults whose acute myeloid leukemia (AML) came back after a stem cell transplant. The main goal was to see if the drug is safe and find the best dose. Researchers also looked at whether the drug could help control the …
Matched conditions: LEUKEMIA, MYELOID, ACUTE
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New hope for leukemia patients: experimental drug combo tested
Disease control CompletedThis study tested a new drug called liposomal annamycin combined with a standard chemotherapy (cytarabine) in 22 adults with acute myeloid leukemia (AML). The goal was to find the safest dose and see how well the combination works against the cancer. Participants had either newly…
Matched conditions: LEUKEMIA, MYELOID, ACUTE
Phase: PHASE1, PHASE2 • Sponsor: Moleculin Biotech, Inc. • Aim: Disease control
Last updated May 13, 2026 16:00 UTC